Key result
Incomplete revascularisation in patients with acute coronary syndromes and multivessel disease was associated with a 2.8-fold increased risk of cardiovascular death and recurrent ACS compared to complete revascularisation.
Why the study?
Does complete revascularisation improve outcomes compared to incomplete revascularisation in patients with ACS and multivessel disease?
Cohort (n=149)
No
Does complete revascularisation improve outcomes compared to incomplete revascularisation in patients with ACS and multivessel disease?
Relative Risk: 2.8 (95% CI 1–8.8)
p-value: p=0.0460
Complete revascularisation during the acute phase of ACS in patients with multivessel disease is associated with better 1-year outcomes compared to incomplete revascularisation.
May support complete revascularisation in ACS with multivessel disease; extends observational data but leaves causal benefit open to RCTs.
BACKGROUND: Interventional treatment improves prognosis in patients with acute coronary syndromes (ACS). However, despite introduction of percutaneous coronary intervention (PCI), the risk of cardiovascular events in patients with multivessel coronary artery disease (MVD) remains significant. AIM: To evaluate the risk of complications and the prognostic value of MVD in patients with ACS during 1-year follow-up. METHODS: A group of 153 patients with ACS was followed up at a single cardiology unit with round-the-clock PCI capability. Treatment of ACS, the extent of revascularisation, and complications occurring during hospitalisation and 1-year follow-up were analysed. The end points of the study were defined as death from all causes, cardiac death, recurrent ACS and a composite end point (deaths from cardiac causes and recurrent ACS). RESULTS: During 1-year follow-up, 11 (7.2%) patients died, including 10 patients with MVD without complete revascularisation. Recurrent ACS occurred in 18 (12%) patients, including 13 patients with MVD without complete revascularisation. Presence of a residual significant coronary stenosis in incompletely revascularised patients with MVD was an important risk factor for all-cause mortality and occurrence of a composite endpoint in comparison to MVD patients who underwent complete revascularisation (p = 0.028 and p = 0.046, respectively) and patients with single-vessel disease (p = 0.006 and p = 0.003, respectively). CONCLUSIONS: Incomplete revascularisation during the acute phase of ACS was associated with an increased risk of complications and a significantly increased risk of all-cause mortality and the combined rate of cardiovascular deaths and recurrent ACS. Single-stage PCI of all significant stenoses in MVD patients resulted in better outcomes.
No takes yet. Share an insight, caveat, or question.
Luczak et al. (2015) conducted a cohort in Acute coronary syndromes and multivessel disease (n=149). Incomplete revascularisation vs. Complete revascularisation was evaluated on Combined endpoint of cardiovascular death and recurrent ACS (RR 2.8, 95% CI 1.0-8.8, p=0.0460). Incomplete revascularisation in patients with acute coronary syndromes and multivessel disease was associated with a 2.8-fold increased risk of cardiovascular death and recurrent ACS compared to complete revascularisation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: